We are live on ! Find out more
CF

Corebridge Financial Portfolio holdings

AUM $4.25M
1-Year Est. Return 33.15%
This Fund
S&P 500
This Quarter Est. Return
+7.52%
1 Year Est. Return
-33.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$18.7B
AUM Growth
+$539M
Cap. Flow
-$486M
Cap. Flow %
-2.59%
Top 10 Hldgs %
25.55%
Holding
3,078
New
21
Increased
334
Reduced
2,669
Closed
33

Top Buys

Rank Stock Value
1
AVTR icon
Avantor
AVTR
+$19.6M
2
PLTR icon
Palantir
PLTR
+$15.2M
3
AAPL icon
Apple
AAPL
+$12.8M
4
CNH
CNH Industrial
CNH
+$10.5M
5
WAL icon
Western Alliance Bancorporation
WAL
+$9.86M

Sector Composition

Rank Sector Weight
1 Technology 28.58%
2 Financials 12.72%
3 Healthcare 11.35%
4 Consumer Discretionary 11.12%
5 Industrials 10.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HOUS
2051
DELISTED
Anywhere Real Estate
HOUS
$267K ﹤0.01%
52,479
-323
-0.6% -$1.5K
CLW icon
2052
Clearwater Paper
CLW
$326M
$266K ﹤0.01%
9,332
-102
-1% -$3.98K
ALK icon
2053
Alaska Air
ALK
$4.59B
$266K ﹤0.01%
5,891
-411
-7% -$15.6K
PKST
2054
DELISTED
Peakstone Realty Trust
PKST
$266K ﹤0.01%
19,525
-121
-0.6% -$1.58K
HONE
2055
DELISTED
HarborOne Bancorp
HONE
$266K ﹤0.01%
20,494
-877
-4% -$10.9K
GOGO icon
2056
Gogo Inc
GOGO
$355M
$266K ﹤0.01%
36,982
-434
-1% -$3.54K
FSBC icon
2057
Five Star Bancorp
FSBC
$1.14B
$265K ﹤0.01%
8,919
+163
+2% +$4.55K
CCNE icon
2058
CNB Financial Corp
CCNE
$1.02B
$265K ﹤0.01%
11,020
-68
-0.6% -$1.58K
ATXS
2059
DELISTED
Astria Therapeutics
ATXS
$265K ﹤0.01%
24,081
-148
-0.6% -$1.65K
PGY icon
2060
Pagaya Technologies
PGY
$1.67B
$264K ﹤0.01%
24,999
+3,266
+15% +$42.9K
GSBC icon
2061
Great Southern Bancorp
GSBC
$874M
$264K ﹤0.01%
4,609
-28
-0.6% -$1.63K
PAHC icon
2062
Phibro Animal Health
PAHC
$1.45B
$264K ﹤0.01%
11,719
-124
-1% -$2.39K
CHCT
2063
Community Healthcare Trust
CHCT
$419M
$264K ﹤0.01%
14,534
-934
-6% -$19.1K
TIPT icon
2064
Tiptree Inc
TIPT
$663M
$264K ﹤0.01%
13,467
-83
-0.6% -$1.54K
LASR icon
2065
nLIGHT
LASR
$2.33B
$263K ﹤0.01%
24,593
-151
-0.6% -$1.71K
SBGI icon
2066
Sinclair Inc
SBGI
$1.01B
$262K ﹤0.01%
17,119
-105
-0.6% -$1.47K
SVRA icon
2067
Savara
SVRA
$1.09B
$262K ﹤0.01%
61,697
+9,529
+18% +$42.1K
RDUS
2068
DELISTED
Radius Recycling
RDUS
$261K ﹤0.01%
14,081
-86
-0.6% -$1.37K
CCBG icon
2069
Capital City Bank Group
CCBG
$868M
$260K ﹤0.01%
7,370
-45
-0.6% -$1.48K
OPK icon
2070
Opko Health
OPK
$1.17B
$259K ﹤0.01%
174,157
-1,075
-0.6% -$1.59K
ERAS icon
2071
Erasca
ERAS
$5.55B
$259K ﹤0.01%
94,904
+34,227
+56% +$96.4K
YMAB
2072
DELISTED
Y-mAbs Therapeutics
YMAB
$259K ﹤0.01%
19,666
-121
-0.6% -$1.53K
GCMG icon
2073
GCM Grosvenor
GCMG
$785M
$258K ﹤0.01%
22,779
+475
+2% +$5.11K
IIIV icon
2074
i3 Verticals
IIIV
$280M
$258K ﹤0.01%
12,091
-75
-0.6% -$1.68K
URGN icon
2075
UroGen Pharma
URGN
$2.07B
$257K ﹤0.01%
20,225
+1,744
+9% +$25.9K

Similar funds

Corebridge Financial's Q3 2024 Portfolio in Review

As of Q3 2024, Corebridge Financial held 3,078 positions worth $18.7B, up 3% from $18.2B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Trading was light in Q3 2024: portfolio turnover was 1.8%. Corebridge Financial opened 21 new positions and exited 33, leaving the 3,078-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 29% a quarter earlier, followed by Financials and Healthcare.

  • Corebridge Financial's largest Q3 2024 buy was Dell: 70,274 shares worth $8.33M.
  • Corebridge Financial added most to Avantor in Q3 2024, an estimated $19.6M increase.
  • Corebridge Financial's biggest Q3 2024 reduction was Microsoft, cutting an estimated $29.5M.
  • Corebridge Financial fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $10.1M.
  • Corebridge Financial's ten largest holdings make up 26% of its $18.7B portfolio in Q3 2024.
  • Corebridge Financial opened 21 new positions and closed 33 in Q3 2024.
  • Corebridge Financial's portfolio value rose 3% quarter-over-quarter to $18.7B.

Based on Corebridge Financial's 13F filing for Q3 2024, filed 13 Nov 2024.